Insight

New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer – MD Anderson Cancer Center

Photo taken from Heiko Enderling/Twitter

Apr 9, 2024, 13:09

New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer – MD Anderson Cancer Center

MD Anderson Cancer Center shared on LinkedIn:

”At the 2024 American Association for Cancer Research Annual Meeting, our Samer Srour and Michael Migden presented results from two clinical trials highlighting novel immunotherapy advances, including a new allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer.
Learn about the findings.”

Source: MD Anderson Cancer Center/LinkedIn

2024 American Association for Cancer Research Annual Meeting AACR AACR24 cancer CAR T-cell therapy Cell Therapy clinical trials immunotherapy kidney cancer MD Anderson Cancer Center Michael Migden OncoDaily Oncology Samer Srour skin cancer

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage